Details of the Drug Inactive Ingredient (DIG)
| General Information of DIG (ID: E0T4YW) | |||||
|---|---|---|---|---|---|
| DIG Name |
Hypromellose
|
||||
| DIG Function |
Coating agent
|
||||
| Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
|---|---|---|---|---|---|---|
| ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
|
Azithromycin
|
API Info |
Congenital syphilis [ICD-11: 1A60]
|
[1] | |||
|
Didanosine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[2] | |||
|
Ribavirin
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[3] | |||
|
Penicillin V
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[4] | |||
|
Ciprofloxacin
|
API Info |
Endocarditis [ICD-11: 1B12]
|
[5] | |||
|
Tinidazole
|
API Info |
Amebiasis [ICD-11: 1A36]
|
[6] | |||
|
Raltegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[7] | |||
|
Chloroquine
|
API Info |
Malaria [ICD-11: 1F40]
|
[8] | |||
|
Lamivudine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[9] | |||
|
Dolutegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[10] | |||
|
Hydroxychloroquine
|
API Info |
Malaria [ICD-11: 1F40]
|
[11] | |||
|
Nelfinavir
|
API Info |
Coronavirus infection [ICD-11: 1D92]
|
[12] | |||
|
Rimantadine
|
API Info |
Influenza virus infection [ICD-11: 1E30]
|
[13] | |||
|
Saquinavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[14] | |||
|
Abacavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[15] | |||
|
Bedaquiline
|
API Info |
Pulmonary tuberculosis [ICD-11: 1B10]
|
[16] | |||
|
Etravirine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[17] | |||
|
Fosamprenavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[18] | |||
|
Rilpivirine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[19] | |||
| ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
|
Bicalutamide
|
API Info |
Prostate cancer [ICD-11: 2C82]
|
[20] | |||
|
Exemestane
|
API Info |
Breast cancer [ICD-11: 2C60]
|
[21] | |||
|
Trametinib
|
API Info |
Melanoma [ICD-11: 2C30]
|
[22] | |||
|
Capecitabine
|
API Info |
Colon cancer [ICD-11: 2B90]
|
[23] | |||
|
Propoxyphene
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[24] | |||
|
Alectinib
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[25] | |||
|
Cabozantinib
|
API Info |
Thyroid cancer [ICD-11: 2D10]
|
[26] | |||
|
Lapatinib
|
API Info |
Breast cancer [ICD-11: 2C60]
|
[27] | |||
|
Anastrozole
|
API Info |
Breast cancer [ICD-11: 2C60]
|
[28] | |||
|
Dabrafenib
|
API Info |
Melanoma [ICD-11: 2C30]
|
[29] | |||
|
Pazopanib
|
API Info |
Renal cell carcinoma [ICD-11: 2C90]
|
[30] | |||
| ICD Disease Classification 03 | Blood/blood-forming organ disease | Click to Show/Hide | ||||
|
Eltrombopag
|
API Info |
Thrombocytopenia [ICD-11: 3B64]
|
[31] | |||
| ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
|
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[32] | |||
| ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
|
Fenofibrate
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[33] | |||
|
Atorvastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[34] | |||
|
Simvastatin
|
API Info |
Dyslipidaemia [ICD-11: 5C81]
|
[35] | |||
|
Pravastatin
|
API Info |
Dyslipidaemia [ICD-11: 5C81]
|
[36] | |||
|
Glipizide
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[37] | |||
|
Rosuvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[38] | |||
|
Metformin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[39] | |||
|
Benzphetamine
|
API Info |
Obesity [ICD-11: 5B81]
|
[40] | |||
|
Liothyronine
|
API Info |
Hypothyroidism [ICD-11: 5A00]
|
[41] | |||
|
Fluvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[42] | |||
|
Alogliptin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[43] | |||
|
Gemfibrozil
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[44] | |||
|
Lorcaserin
|
API Info |
Obesity [ICD-11: 5B81]
|
[45] | |||
|
Eliglustat
|
API Info |
Gaucher disease [ICD-11: 5C56]
|
[46] | |||
|
Pitavastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[47] | |||
| ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
|
Risperidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[48] | |||
|
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[49] | |||
|
Alprazolam
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[50] | |||
|
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[51] | |||
|
Duloxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[52] | |||
|
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[53] | |||
|
Sertraline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[54] | |||
|
Amitriptyline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[55] | |||
|
Olanzapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[56] | |||
|
Hydroxyzine
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[57] | |||
|
Paroxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[58] | |||
|
Quetiapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[59] | |||
|
Guanfacine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[60] | |||
|
Cyclobenzaprine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[61] | |||
|
Mirtazapine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[62] | |||
|
Imipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[63] | |||
|
Prochlorperazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[64] | |||
|
Fluphenazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[65] | |||
|
Trazodone
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[66] | |||
|
Buprenorphine
|
API Info |
Opiate dependence [ICD-11: 6C43]
|
[67] | |||
|
Trifluoperazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[68] | |||
|
Citalopram
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[69] | |||
|
Carisoprodol
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[70] | |||
|
Tranylcypromine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[71] | |||
|
Vortioxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[72] | |||
|
Lorazepam
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[73] | |||
|
Protriptyline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[74] | |||
|
Thioridazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[75] | |||
|
Lurasidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[76] | |||
|
Perphenazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[77] | |||
|
Naltrexone
|
API Info |
Alcohol dependence [ICD-11: 6C40]
|
[78] | |||
| ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
|
Zolpidem
|
API Info |
Insomnia [ICD-11: 7A00]
|
[79] | |||
|
Ramelteon
|
API Info |
Insomnia [ICD-11: 7A00]
|
[80] | |||
| ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
|
Acetaminophen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[81] | |||
|
Morphine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[82] | |||
|
Gabapentin
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[83] | |||
|
Oxycodone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[84] | |||
|
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[85] | |||
|
Ropinirole
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[86] | |||
|
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[87] | |||
|
Carbamazepine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[88] | |||
|
Tizanidine
|
API Info |
Tic disorder [ICD-11: 8A05]
|
[89] | |||
|
Topiramate
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[90] | |||
|
Galantamine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[91] | |||
|
Memantine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[92] | |||
|
Rivastigmine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[93] | |||
|
Tiagabine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[94] | |||
|
Tapentadol
|
API Info |
Neuropathic pain [ICD-11: 8E43]
|
[95] | |||
|
Sumatriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[96] | |||
|
Valbenazine
|
API Info |
Dyskinesia [ICD-11: 8A02]
|
[97] | |||
|
Pimavanserin
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[98] | |||
|
Frovatriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[99] | |||
|
Safinamide
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[100] | |||
| ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
|
Diltiazem
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[101] | |||
|
Aspirin
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[102] | |||
|
Metoprolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[103] | |||
|
Verapamil
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[104] | |||
|
Losartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[105] | |||
|
Enalapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[106] | |||
|
Caffeine
|
API Info |
Orthostatic hypotension [ICD-11: BA21]
|
[107] | |||
|
Felodipine
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[108] | |||
|
Nifedipine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[109] | |||
|
Propafenone
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[110] | |||
|
Benazepril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[111] | |||
|
Carvedilol
|
API Info |
Congestive heart failure [ICD-11: BD10]
|
[112] | |||
|
Spironolactone
|
API Info |
Congestive heart failure [ICD-11: BD10]
|
[113] | |||
|
Trandolapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[114] | |||
|
Nisoldipine
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[115] | |||
|
Isosorbide dinitrate
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[116] | |||
|
Labetalol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[117] | |||
|
Prasugrel
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[118] | |||
|
Indapamide
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[119] | |||
|
Pentoxifylline
|
API Info |
Intermittent claudication [ICD-11: BD40]
|
[120] | |||
|
Betaxolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[121] | |||
|
Bisoprolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[122] | |||
|
Cilostazol
|
API Info |
Intermittent claudication [ICD-11: BD40]
|
[123] | |||
|
Quinapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[124] | |||
|
Dabigatran etexilate
|
API Info |
Venous thromboembolism [ICD-11: BD72]
|
[125] | |||
|
Penbutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[126] | |||
|
Aliskiren
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[127] | |||
|
Dronedarone
|
API Info |
Atrial fibrillation [ICD-11: BC81]
|
[128] | |||
|
Eprosartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[129] | |||
|
Ivabradine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[130] | |||
|
Moexipril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[131] | |||
|
Vorapaxar
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[132] | |||
| ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
|
Montelukast
|
API Info |
Asthma [ICD-11: CA23]
|
[133] | |||
|
Guaifenesin
|
API Info |
Asthma [ICD-11: CA23]
|
[134] | |||
|
Clarithromycin
|
API Info |
Pneumocystis pneumonia [ICD-11: CA40]
|
[135] | |||
|
Fexofenadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[136] | |||
|
Promethazine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[137] | |||
|
Loratadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[138] | |||
|
Levofloxacin
|
API Info |
Bronchitis [ICD-11: CA20]
|
[139] | |||
|
Cefpodoxime
|
API Info |
Bronchitis [ICD-11: CA20]
|
[140] | |||
|
Theophylline
|
API Info |
Chronic obstructive pulmonary disease [ICD-11: CA22]
|
[141] | |||
|
Levocetirizine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[142] | |||
|
Zafirlukast
|
API Info |
Asthma [ICD-11: CA23]
|
[143] | |||
| ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
|
Doxycycline
|
API Info |
Periodontal disease [ICD-11: DA0C]
|
[144] | |||
|
Omeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[145] | |||
|
Pantoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[146] | |||
|
Simethicone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[147] | |||
|
Ranitidine
|
API Info |
Gastric ulcer [ICD-11: DA60]
|
[148] | |||
|
Esomeprazole
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[149] | |||
|
Dicyclomine
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[150] | |||
|
Ondansetron
|
API Info |
Gastritis [ICD-11: DA42]
|
[151] | |||
|
Mycophenolate mofetil
|
API Info |
Crohn disease [ICD-11: DD70]
|
[152] | |||
|
Cimetidine
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[153] | |||
|
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[154] | |||
|
Dexlansoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[155] | |||
|
Naloxegol
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[156] | |||
|
Naldemedine
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[156] | |||
|
Granisetron
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[157] | |||
| ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
|
Propantheline
|
API Info |
Excessive sweating [ICD-11: EE00]
|
[158] | |||
|
Terbinafine
|
API Info |
Onychomycosis [ICD-11: EE12]
|
[159] | |||
| ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
|
Naproxen
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[160] | |||
|
Diclofenac
|
API Info |
Knee osteoarthritis [ICD-11: FA01]
|
[161] | |||
|
Nabumetone
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[162] | |||
|
Risedronic acid
|
API Info |
Paget's disease [ICD-11: FB85]
|
[163] | |||
|
Tolmetin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[164] | |||
|
Raloxifene
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[165] | |||
|
Ketorolac
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[166] | |||
|
Flavoxate
|
API Info |
Knee osteoarthritis [ICD-11: FA01]
|
[167] | |||
|
Leflunomide
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[168] | |||
|
Testosterone
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[169] | |||
|
Tofacitinib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[170] | |||
| ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
|
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[171] | |||
|
Oxybutynin
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[172] | |||
|
Erythromycin
|
API Info |
Pelvic inflammatory disease [ICD-11: GA05]
|
[173] | |||
|
Tolterodine
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[174] | |||
|
Darifenacin
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[175] | |||
| ICD Disease Classification 17 | Sexual health-related condition | Click to Show/Hide | ||||
|
Tadalafil
|
API Info |
Erectile dysfunction [ICD-11: HA01]
|
[176] | |||
| ICD Disease Classification 18 | Pregnancy/childbirth/puerperium condition | Click to Show/Hide | ||||
|
Misoprostol
|
API Info |
Medical abortion [ICD-11: JA00]
|
[177] | |||
| Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
|---|---|---|---|---|---|---|
| Oxidoreductase (ORase) | ||||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [178] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [178] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| DBT Name: Cytochrome P450 2E1 (CYP2E1) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 253.5 uM (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2E1_HUMAN | |||||
| DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | EC50 = 211.8 uM (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2CJ_HUMAN | |||||
| DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | EC50 = 159.3 uM (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2D6_HUMAN | |||||
| DBT Name: Cytochrome P450 3A5 (CYP3A5) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 19.4 uM (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A5_HUMAN | |||||
| Lyase/isomerase/ligase (L/I/G) | ||||||
| DBT Name: Cholesterol 25-hydroxylase (CYP1A2) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | EC50 = 106.7 uM (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP1A2_HUMAN | |||||
| Cell line (CELL) | ||||||
| DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Promotion ratio > 18 % (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Promotion ratio > 27 % (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

